Annechien E. G. Haarman

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Treatment of Guillain-Barré syndrome with a standard course of high-dose intravenous immunoglobulin (IVIg) results in a variable clinical recovery which is associated with changes in serum IgG levels after treatment. The neonatal Fc-receptor protects IgG from degradation, and a genetic polymorphism in its promoter region that influences the expression of(More)
  • 1